|
|
|
|
| LEADER |
01000caa a2200265 4500 |
| 001 |
OLC1989809820 |
| 003 |
DE-627 |
| 005 |
20230515132331.0 |
| 007 |
tu |
| 008 |
170207s2017 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a PQ20170206
|
| 035 |
|
|
|a (DE-627)OLC1989809820
|
| 035 |
|
|
|a (DE-599)GBVOLC1989809820
|
| 035 |
|
|
|a (PRQ)benthamscience_primary_http_www_eurekaselect_com_openurl_content_php_genre_article_issn_1568_0266_volume_17_issue_2_spage_930
|
| 035 |
|
|
|a (KEY)0446467220170000017000200093perspectiveinmedicinalchemistrystructurebaseddrugd
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
4 |
|a 540
|q DNB
|
| 084 |
|
|
|a PHARM
|2 fid
|
| 084 |
|
|
|a 44.40
|2 bkl
|
| 100 |
0 |
|
|a Miles Congreve
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Perspective in Medicinal Chemistry: Structure-Based Drug Design
|
| 264 |
|
1 |
|c 2017
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 700 |
0 |
|
|a Steve Andrews
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|t Current topics in medicinal chemistry
|d Hilversum [u.a.] : Bentham Science Publ., 2001
|g 17(2017), 2, Seite 93-94
|w (DE-627)338770283
|w (DE-600)2064823-6
|w (DE-576)435515160
|x 1568-0266
|7 nnns
|
| 773 |
1 |
8 |
|g volume:17
|g year:2017
|g number:2
|g pages:93-94
|
| 856 |
4 |
2 |
|u http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1568-0266&volume=17&issue=2&spage=93
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_OLC
|
| 912 |
|
|
|a FID-PHARM
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OLC-DE-84
|
| 912 |
|
|
|a SSG-OPC-PHA
|
| 912 |
|
|
|a GBV_ILN_4219
|
| 936 |
b |
k |
|a 44.40
|q AVZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 17
|j 2017
|e 2
|h 93-94
|
